Birdwatch Note
2024-12-28 09:12:05 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
名誉毀損における真実性の立証責任は被告側にあり、真実性の立証がない限り、原告側には反証責任はありません https://laws.e-gov.go.jp/law/140AC0000000045#Mp-Pa_2-Ch_34-At_230_2 よって、本件では原口一博に「生物兵器まがい」「殺人に近い話」等の真実性の立証責任があります https://www3.nhk.or.jp/lnews/saga/20241226/5080018637.html 真実性の立証がないゆえに提訴されたのだから、裁判で一転して立証できると考えることは無理があり、動画は明らかな現実逃避です。 尚、コスタイベ(レプリコン)の安全性と有効性は治験で良好と評価されています。 死亡はプラセボ群が16(うち、新型コロナ9)接種群では5(うち、新型コロナ1)と減少しており、特段の懸念は認められません https://doi.org/10.1038/s41467-024-47905-1 https://www.mhlw.go.jp/content/10906000/001316061.pdf https://www.pmda.go.jp/drugs/2024/P20240917001/780009000_30500AMX00282_A100_1.pdf https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/vaccine_qa.html#20
Written by EE7192EF0B1C47D8A3430C3E070DA2A0BFAA58717F9133404318E9D7666B1A00
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1872665824689045662
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1872933527504994668
- noteId - 1872933527504994668
- participantId -
- noteAuthorParticipantId - EE7192EF0B1C47D8A3430C3E070DA2A0BFAA58717F9133404318E9D7666B1A00 Participant Details
- createdAtMillis - 1735377125036
- tweetId - 1872665824689045662
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 1
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- 名誉毀損における真実性の立証責任は被告側にあり、真実性の立証がない限り、原告側には反証責任はありません https://laws.e-gov.go.jp/law/140AC0000000045#Mp-Pa_2-Ch_34-At_230_2 よって、本件では原口一博に「生物兵器まがい」「殺人に近い話」等の真実性の立証責任があります https://www3.nhk.or.jp/lnews/saga/20241226/5080018637.html 真実性の立証がないゆえに提訴されたのだから、裁判で一転して立証できると考えることは無理があり、動画は明らかな現実逃避です。 尚、コスタイベ(レプリコン)の安全性と有効性は治験で良好と評価されています。 死亡はプラセボ群が16(うち、新型コロナ9)接種群では5(うち、新型コロナ1)と減少しており、特段の懸念は認められません https://doi.org/10.1038/s41467-024-47905-1 https://www.mhlw.go.jp/content/10906000/001316061.pdf https://www.pmda.go.jp/drugs/2024/P20240917001/780009000_30500AMX00282_A100_1.pdf https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/vaccine_qa.html#20
Note Ratings
| rated at | rated by | |
| 2024-12-28 17:17:35 -0600 | Rating Details | |
| 2024-12-28 16:18:39 -0600 | Rating Details | |
| 2024-12-28 13:04:47 -0600 | Rating Details | |
| 2024-12-28 09:43:13 -0600 | Rating Details | |
| 2024-12-28 09:17:47 -0600 | Rating Details | |
| 2024-12-28 07:37:44 -0600 | Rating Details | |
| 2024-12-28 07:11:03 -0600 | Rating Details | |
| 2024-12-28 06:17:35 -0600 | Rating Details | |
| 2024-12-28 06:07:14 -0600 | Rating Details | |
| 2024-12-28 05:40:19 -0600 | Rating Details | |
| 2024-12-28 05:33:42 -0600 | Rating Details | |
| 2024-12-28 04:03:50 -0600 | Rating Details | |
| 2024-12-28 04:00:44 -0600 | Rating Details | |
| 2024-12-28 03:59:44 -0600 | Rating Details | |
| 2024-12-28 03:47:32 -0600 | Rating Details | |
| 2024-12-28 03:34:00 -0600 | Rating Details | |
| 2024-12-28 03:33:49 -0600 | Rating Details | |
| 2024-12-28 03:32:28 -0600 | Rating Details | |
| 2024-12-28 03:32:09 -0600 | Rating Details | |
| 2024-12-28 03:30:31 -0600 | Rating Details | |
| 2024-12-28 03:29:29 -0600 | Rating Details | |
| 2024-12-29 16:00:38 -0600 | Rating Details | |
| 2024-12-29 05:53:17 -0600 | Rating Details | |
| 2024-12-28 18:26:20 -0600 | Rating Details | |
| 2024-12-28 17:27:57 -0600 | Rating Details | |
| 2024-12-28 15:27:23 -0600 | Rating Details | |
| 2024-12-28 12:35:20 -0600 | Rating Details | |
| 2024-12-28 10:13:59 -0600 | Rating Details | |
| 2024-12-28 08:08:08 -0600 | Rating Details | |
| 2024-12-28 07:58:34 -0600 | Rating Details | |
| 2024-12-28 06:55:03 -0600 | Rating Details | |
| 2024-12-28 06:18:15 -0600 | Rating Details | |
| 2024-12-28 05:49:03 -0600 | Rating Details | |
| 2024-12-28 05:36:53 -0600 | Rating Details | |
| 2024-12-28 05:29:07 -0600 | Rating Details | |
| 2024-12-28 04:28:36 -0600 | Rating Details | |
| 2024-12-28 04:13:46 -0600 | Rating Details | |
| 2024-12-28 04:10:27 -0600 | Rating Details | |
| 2024-12-28 04:06:53 -0600 | Rating Details | |
| 2024-12-28 03:58:01 -0600 | Rating Details | |
| 2024-12-28 03:51:41 -0600 | Rating Details | |
| 2024-12-28 03:44:23 -0600 | Rating Details | |
| 2024-12-28 03:43:43 -0600 | Rating Details | |
| 2024-12-28 03:40:59 -0600 | Rating Details | |
| 2024-12-28 03:38:35 -0600 | Rating Details | |
| 2024-12-28 03:37:37 -0600 | Rating Details | |
| 2024-12-28 03:32:30 -0600 | Rating Details | |
| 2024-12-28 03:32:27 -0600 | Rating Details | |
| 2024-12-28 03:30:42 -0600 | Rating Details | |
| 2024-12-28 03:26:50 -0600 | Rating Details | |
| 2024-12-28 03:25:14 -0600 | Rating Details | |
| 2025-01-04 04:30:15 -0600 | Rating Details | |
| 2024-12-30 05:59:31 -0600 | Rating Details | |
| 2024-12-28 20:51:05 -0600 | Rating Details | |
| 2024-12-28 17:16:22 -0600 | Rating Details | |
| 2024-12-28 11:23:15 -0600 | Rating Details | |
| 2024-12-28 08:12:25 -0600 | Rating Details | |
| 2024-12-28 06:29:37 -0600 | Rating Details | |
| 2024-12-28 05:52:12 -0600 | Rating Details | |
| 2024-12-28 05:30:04 -0600 | Rating Details | |
| 2024-12-28 04:55:30 -0600 | Rating Details | |
| 2024-12-28 04:43:00 -0600 | Rating Details | |
| 2024-12-28 04:20:10 -0600 | Rating Details | |
| 2024-12-28 04:19:12 -0600 | Rating Details | |
| 2024-12-28 03:57:56 -0600 | Rating Details | |
| 2024-12-28 03:52:12 -0600 | Rating Details | |
| 2024-12-28 03:45:01 -0600 | Rating Details | |
| 2024-12-28 03:44:09 -0600 | Rating Details | |
| 2024-12-28 03:42:34 -0600 | Rating Details | |
| 2024-12-28 03:35:02 -0600 | Rating Details | |
| 2024-12-28 03:24:45 -0600 | Rating Details |